• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环 miRNA 的失调促进了糖尿病性心肌病的发病机制。

Dysregulation of circulating miRNAs promotes the pathogenesis of diabetes-induced cardiomyopathy.

机构信息

Department of Bioinformatics and Biotechnology, Government College University, Faisalabad, Pakistan.

Department of Physiology and Cell Biology, University of Health Sciences, Lahore, Pakistan.

出版信息

PLoS One. 2021 Apr 28;16(4):e0250773. doi: 10.1371/journal.pone.0250773. eCollection 2021.

DOI:10.1371/journal.pone.0250773
PMID:33909697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8081166/
Abstract

Diabetic Cardiomyopathy (DCM) is characterized by myocardial dysfunction caused by diabetes mellitus. After-effects of diabetic cardiomyopathy are far more lethal than non-diabetic cardiomyopathy. More than 300 million people suffer from diabetes and cardiovascular disorder which is expected to be elevated to an alarming figure of 450 million by 2030. Recent studies suggested that miRNA plays important role in the onset of diabetic cardiomyopathy. This study was designed to identify the miRNA that is responsible for the onset of diabetic cardiomyopathy using in silico and in vitro approaches. In this study, to identify the miRNA responsible for the onset of diabetic cardiomyopathy, in silico analysis was done to predict the role of these circulating miRNAs in type 2 diabetic cardiomyopathy. Shared miRNAs that are present in both diseases were selected for further analysis. Total RNA and miRNA were extracted from blood samples taken from type 2 diabetic patients as well as healthy controls to analyze the expression of important genes like AKT, VEGF, IGF, FGF1, ANGPT2 using Real-time PCR. The expression of ANGPT2 was up-regulated and AKT, VEGF, IGF, FGF1 were down-regulated in DCM patients as compared to healthy controls. The miRNA expression of miR-17 was up-regulated and miR-24, miR-150, miR-199a, miR-214, and miR-320a were down-regulated in the DCM patients as compared to healthy controls. This shows that dysregulation of target genes and miRNA may contribute towards the pathogenesis of DCM and more studies should be conducted to elucidate the role of circulating miRNAs to use them as therapeutic and diagnostic options.

摘要

糖尿病心肌病(DCM)的特征是由糖尿病引起的心肌功能障碍。糖尿病性心肌病的后遗症比非糖尿病性心肌病更为致命。目前全球有超过 3 亿人患有糖尿病和心血管疾病,预计到 2030 年这一数字将上升到令人震惊的 4.5 亿。最近的研究表明,miRNA 在糖尿病性心肌病的发病中起重要作用。本研究旨在通过计算机模拟和体外方法确定导致糖尿病性心肌病发病的 miRNA。在这项研究中,为了确定导致糖尿病性心肌病发病的 miRNA,通过计算机模拟分析预测这些循环 miRNA 在 2 型糖尿病性心肌病中的作用。选择两种疾病都存在的共享 miRNA 进行进一步分析。从 2 型糖尿病患者和健康对照者的血液样本中提取总 RNA 和 miRNA,使用实时 PCR 分析 AKT、VEGF、IGF、FGF1、ANGPT2 等重要基因的表达。与健康对照组相比,DCM 患者的 ANGPT2 表达上调,AKT、VEGF、IGF、FGF1 表达下调。与健康对照组相比,DCM 患者的 miR-17 表达上调,miR-24、miR-150、miR-199a、miR-214 和 miR-320a 表达下调。这表明靶基因和 miRNA 的失调可能导致 DCM 的发病机制,应进行更多的研究以阐明循环 miRNA 的作用,将其作为治疗和诊断选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b22/8081166/e3743777a08a/pone.0250773.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b22/8081166/c6d5f6dd640d/pone.0250773.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b22/8081166/e15778f429d6/pone.0250773.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b22/8081166/dac5f357ebd5/pone.0250773.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b22/8081166/3da1a7ad9859/pone.0250773.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b22/8081166/e3743777a08a/pone.0250773.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b22/8081166/c6d5f6dd640d/pone.0250773.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b22/8081166/e15778f429d6/pone.0250773.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b22/8081166/dac5f357ebd5/pone.0250773.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b22/8081166/3da1a7ad9859/pone.0250773.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b22/8081166/e3743777a08a/pone.0250773.g005.jpg

相似文献

1
Dysregulation of circulating miRNAs promotes the pathogenesis of diabetes-induced cardiomyopathy.循环 miRNA 的失调促进了糖尿病性心肌病的发病机制。
PLoS One. 2021 Apr 28;16(4):e0250773. doi: 10.1371/journal.pone.0250773. eCollection 2021.
2
Value of circulating miRNA-21 in the diagnosis of subclinical diabetic cardiomyopathy.循环 miRNA-21 在亚临床糖尿病性心肌病诊断中的价值。
Mol Cell Endocrinol. 2020 Dec 1;518:110944. doi: 10.1016/j.mce.2020.110944. Epub 2020 Jul 24.
3
Expression profiles and bioinformatic analysis of microRNAs in myocardium of diabetic cardiomyopathy mice.糖尿病心肌病小鼠心肌中 microRNAs 的表达谱和生物信息学分析。
Genes Genomics. 2023 Aug;45(8):1003-1011. doi: 10.1007/s13258-023-01403-8. Epub 2023 May 30.
4
Pathogenesis of Diabetic Cardiomyopathy and Role of miRNA.糖尿病心肌病的发病机制及 miRNA 的作用。
Crit Rev Eukaryot Gene Expr. 2021;31(1):79-92. doi: 10.1615/CritRevEukaryotGeneExpr.2021037533.
5
MicroRNA-1281 as a Novel Circulating Biomarker in Patients With Diabetic Retinopathy.miR-1281 作为糖尿病视网膜病变患者的新型循环生物标志物。
Front Endocrinol (Lausanne). 2020 Aug 4;11:528. doi: 10.3389/fendo.2020.00528. eCollection 2020.
6
Identification and analysis of circulating long non-coding RNAs with high significance in diabetic cardiomyopathy.鉴定和分析在糖尿病心肌病中具有重要意义的循环长非编码 RNA。
Sci Rep. 2021 Jan 28;11(1):2571. doi: 10.1038/s41598-021-82345-7.
7
Serum circulating microRNA profiling for identification of potential type 2 diabetes and obesity biomarkers.血清循环 microRNA 谱分析鉴定潜在的 2 型糖尿病和肥胖生物标志物。
PLoS One. 2013 Oct 15;8(10):e77251. doi: 10.1371/journal.pone.0077251. eCollection 2013.
8
MicroRNA profiling unveils hyperglycaemic memory in the diabetic heart.miRNA 谱分析揭示糖尿病心脏中的高血糖记忆。
Eur Heart J. 2016 Feb 7;37(6):572-6. doi: 10.1093/eurheartj/ehv599. Epub 2015 Nov 9.
9
Plasma microRNAs as biomarkers for Lamin A/C-related dilated cardiomyopathy.血浆 microRNAs 作为核纤层蛋白 A/C 相关扩张型心肌病的生物标志物。
J Mol Med (Berl). 2018 Aug;96(8):845-856. doi: 10.1007/s00109-018-1666-1. Epub 2018 Jul 14.
10
MicroRNA dysregulation in diabetic ischemic heart failure patients.糖尿病缺血性心力衰竭患者中 microRNA 的失调。
Diabetes. 2012 Jun;61(6):1633-41. doi: 10.2337/db11-0952. Epub 2012 Mar 16.

引用本文的文献

1
The interregulatory circuit between non-coding RNA and apoptotic signaling in diabetic cardiomyopathy.糖尿病性心肌病中,非编码RNA与凋亡信号之间的相互调节回路。
Noncoding RNA Res. 2024 Jun 12;9(4):1080-1097. doi: 10.1016/j.ncrna.2024.06.011. eCollection 2024 Dec.
2
Retraction: Dysregulation of circulating miRNAs promotes the pathogenesis of diabetes-induced cardiomyopathy.撤稿声明:循环微小RNA的失调促进糖尿病性心肌病的发病机制。
PLoS One. 2023 Dec 22;18(12):e0296476. doi: 10.1371/journal.pone.0296476. eCollection 2023.
3
The role of microRNAs in pathophysiology and diagnostics of metabolic complications in obstructive sleep apnea patients.

本文引用的文献

1
Pathogenesis of Diabetic Cardiomyopathy and Role of miRNA.糖尿病心肌病的发病机制及 miRNA 的作用。
Crit Rev Eukaryot Gene Expr. 2021;31(1):79-92. doi: 10.1615/CritRevEukaryotGeneExpr.2021037533.
2
Established and Emerging Mechanisms of Diabetic Cardiomyopathy.糖尿病心肌病的既定机制与新出现机制
J Lipid Atheroscler. 2019 May;8(1):26-47. doi: 10.12997/jla.2019.8.1.26. Epub 2019 May 13.
3
LncRNA-MIAT-Mediated miR-214-3p Silencing Is Responsible for IL-17 Production and Cardiac Fibrosis in Diabetic Cardiomyopathy.长链非编码RNA-MIAT介导的miR-214-3p沉默导致糖尿病心肌病中白细胞介素-17的产生和心脏纤维化。
微小RNA在阻塞性睡眠呼吸暂停患者代谢并发症的病理生理学及诊断中的作用
Front Mol Neurosci. 2023 Jul 21;16:1208886. doi: 10.3389/fnmol.2023.1208886. eCollection 2023.
4
Exploring the Complex Relationship between Diabetes and Cardiovascular Complications: Understanding Diabetic Cardiomyopathy and Promising Therapies.探索糖尿病与心血管并发症之间的复杂关系:了解糖尿病性心肌病及有前景的治疗方法。
Biomedicines. 2023 Apr 7;11(4):1126. doi: 10.3390/biomedicines11041126.
5
Diabetic cardiomyopathy: Clinical phenotype and practice.糖尿病心肌病:临床表型与实践。
Front Endocrinol (Lausanne). 2022 Dec 7;13:1032268. doi: 10.3389/fendo.2022.1032268. eCollection 2022.
6
Evaluation of Circulating MicroRNAs and Adipokines in Breast Cancer Survivors with Arm Lymphedema.评估伴有上肢淋巴水肿的乳腺癌幸存者的循环 microRNAs 和脂肪因子。
Int J Mol Sci. 2022 Sep 26;23(19):11359. doi: 10.3390/ijms231911359.
7
Molecular and cellular mechanisms in diabetic heart failure: Potential therapeutic targets.糖尿病性心力衰竭的分子和细胞机制:潜在的治疗靶点。
Front Endocrinol (Lausanne). 2022 Sep 2;13:947294. doi: 10.3389/fendo.2022.947294. eCollection 2022.
8
MicroRNAs as biomarkers for monitoring cardiovascular changes in Type II Diabetes Mellitus (T2DM) and exercise.微小RNA作为监测2型糖尿病(T2DM)和运动中心血管变化的生物标志物。
J Diabetes Metab Disord. 2022 Jul 7;21(2):1819-1832. doi: 10.1007/s40200-022-01066-4. eCollection 2022 Dec.
9
The potential role of miR-27a and miR-320a in metabolic syndrome in obese Egyptian females.miR-27a和miR-320a在肥胖埃及女性代谢综合征中的潜在作用。
J Genet Eng Biotechnol. 2022 May 19;20(1):75. doi: 10.1186/s43141-022-00348-x.
Front Cell Dev Biol. 2020 Apr 15;8:243. doi: 10.3389/fcell.2020.00243. eCollection 2020.
4
Downregulation of circulating miR-320a and target gene prediction in patients with diabetic retinopathy.糖尿病视网膜病变患者循环miR-320a的下调及靶基因预测
BMC Res Notes. 2020 Mar 16;13(1):155. doi: 10.1186/s13104-020-05001-9.
5
Mitochondrial Mechanisms in Diabetic Cardiomyopathy.糖尿病心肌病中的线粒体机制。
Diabetes Metab J. 2020 Feb;44(1):33-53. doi: 10.4093/dmj.2019.0185.
6
STAT3-miR-17/20 signalling axis plays a critical role in attenuating myocardial infarction following rapamycin treatment in diabetic mice.STAT3-miR-17/20 信号轴在雷帕霉素治疗糖尿病小鼠心肌梗死后发挥关键作用。
Cardiovasc Res. 2020 Nov 1;116(13):2103-2115. doi: 10.1093/cvr/cvz315.
7
A review of fibroblast growth factor 21 in diabetic cardiomyopathy.成纤维细胞生长因子 21 在糖尿病心肌病中的研究进展。
Heart Fail Rev. 2019 Nov;24(6):1005-1017. doi: 10.1007/s10741-019-09809-x.
8
Circulating miR-26a-1, miR-146a and miR-199a-1 are potential candidate biomarkers for acute myocardial infarction.循环 miR-26a-1、miR-146a 和 miR-199a-1 是急性心肌梗死的潜在候选生物标志物。
Mol Med. 2019 May 15;25(1):18. doi: 10.1186/s10020-019-0086-1.
9
Cardiovascular disease risk factors in Pakistani population with newly diagnosed Type 2 diabetes mellitus: A cross-sectional study of selected family practitioner clinics in four provinces of Pakistan (CardiP Study).巴基斯坦新诊断2型糖尿病患者的心血管疾病危险因素:对巴基斯坦四个省份选定的家庭医生诊所进行的横断面研究(CardiP研究)
J Pak Med Assoc. 2019 Mar;69(3):306-312.
10
Diabetic Cardiomyopathy: Current and Future Therapies. Beyond Glycemic Control.糖尿病性心肌病:当前及未来的治疗方法。超越血糖控制。
Front Physiol. 2018 Oct 30;9:1514. doi: 10.3389/fphys.2018.01514. eCollection 2018.